UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) ~~April 14~~January 5, ~~2005~~2009

LIFE SCIENCES, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-05099	59-0995081
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or other jurisdictionof incorporation)	(Commission File Number)	(IRS EmployerIdentification No.)


2900 – 72nd Street North, St. Petersburg, Florida		33710
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (727) 345-9371

Not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Forward-looking Statements

Some of the statements in this Form 8-K are “forward-looking statements” and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that these forward-looking statements reflect numerous assumptions, known and unknown risks, uncertainties and other factors that may affect the business and prospects of Life Sciences, Inc. and cause the actual results, performance or achievements of Life Sciences, Inc. to differ materially from those expressed or implied by the forward-looking statements. These factors include: longer product development lead times; delays in product roll outs; lack of performance or allegations thereof in contractual relationships; unfavorable results in dispute resolution proceedings or governmental applications; failure to obtain anticipated contracts with third parties or orders from customers, or less favorable contracts with third parties or lower than expected volumes from customers; higher material and labor costs; unfavorable patent or other technology decisions; the availability of adequate sources of working capital and cash flow; economic, health and political conditions, especially in international markets, including infectious diseases, civil unrest, military actions, governmental changes and restrictions on the ability to transfer capital across borders; and economic, competitive, technological, diplomatic, governmental and other factors.

Non Regulation FD Filing

This Form 8-K is being filed for reasons other than those that would require a filing under Regulation FD.

Item 8.01.

Other Events.

OnNew ~~April~~Florida ~~14,~~Lawsuit 2005, Life Sciences, Inc. (the “Company,” “LSI” or “Life Sciences”) received a certified letter dated April 7, 2005 from the Securities and Exchange Commission (“SEC” or the “Commission”) regarding LSI’s lack of compliance with the reporting requirements under Section 13(a) of the Securities Exchange Act of 1934. This lack of compliance under the Securities Exchange Act goes principally to the lack of filings of annual reports (on Form 10-KSB) and of quarterly reports (on Form 10-QSB) by the Company.

~~The~~On ~~SEC’s~~December 30, ~~letter~~2008, ~~stated~~five ~~that~~entities ~~all~~holding ~~required~~six ~~reports~~convertible ~~should~~promissory benotes ~~filed~~issued ~~within~~by 15Life ~~days~~Sciences, ~~from~~Inc., ~~the~~which ~~date~~entities ofare ~~the~~controlled ~~letter.~~by ~~That~~Simon Srybnik ~~time~~and ~~period~~his ~~expired~~brother onLouis orD. ~~about~~Srybnik ~~April~~(the ~~22,~~direct ~~2005,~~ and noindirect, ~~additional~~through ~~reports~~various ~~had~~entities ~~been~~controlled ~~filed~~ by ~~that date. The April 7~~them, ~~2005~~beneficial ~~letter~~owners ~~also~~of ~~advised~~more ~~that~~than if60% ~~all~~ of the ~~required~~Common ~~reports~~Stock ~~were~~of ~~not~~Life ~~filed~~Sciences, ~~within~~Inc.) 15filed ~~days~~an ~~from~~action ~~the~~in ~~date of~~ the ~~letter,~~Circuit ~~the~~Court ~~Company~~of ~~may~~Pinellas ~~be subject~~County, ~~without further notice, to an~~ ~~administrative~~Florida ~~proceeding~~seeking ~~brought~~in byexcess ~~the SEC’s Division~~ of ~~Enforcement~~$756,000 alleged to ~~revoke~~be ~~the~~due ~~registration~~on ~~under~~ the ~~Securities~~notes, ~~Exchange~~plus ~~Act~~interest ofand ~~the Company~~attorneys’s ~~common stock~~fees.

IfThis ~~the~~action ~~registration~~has ofyet ~~the common stock were~~ to be served. ~~revoked,~~It ~~then~~was nodiscovered ~~member~~through ofpublic arecords ~~national~~when ~~securities~~checking ~~exchange, broker or dealer may use~~ the ~~mails~~ orCourt’s ~~other~~website ~~means~~docket ofwith ~~interstate~~respect ~~commerce~~ to ~~effect any transaction in~~ the ~~common~~status ~~stock,~~of ~~or to induce~~ the ~~purchase~~eviction oraction ~~sale~~pending ofin the ~~common~~Pinellas ~~stock. Accordingly~~County, itFlorida ~~would~~County ~~be expected that all trading of the common stock would cease if the Commission revokes the registration of the common stock under the Securities Exchange Act~~Court.

~~The~~Florida ~~failure~~Premises toEviction ~~file~~Litigation periodic reports under the Securities Exchange Act was separately reported by the Company under the caption “Annual and Other Reports” in its Form 8-K’s filed with the SEC on March 5, 2004 and April 11, 2005.

~~The~~A hearing ~~Company~~is ~~has~~scheduled ~~been~~to inbe ~~contact~~held ~~with~~on ~~the Commission regarding the April 7~~March 5, ~~2005~~2009 ~~letter.~~in ~~This~~this ~~contact~~eviction ~~has~~action ~~been~~brought ~~through telephone conversations and~~ by a186-194 ~~letter~~Imlay ~~dated~~St. ~~April~~Realty ~~21, 2005~~Corp. ~~Through these contacts~~(“Imlay”), ~~the Company has attempted to briefly convey, among other matters,~~ a ~~summary~~New ofYork ~~some~~corporation ofcontrolled ~~the major difficulties faced~~ by ~~the~~Simon ~~Company~~Srybnik ~~that~~and ~~have~~Louis ~~contributed~~D. Srybnik to ~~the~~remove ~~lack~~Life ofSciences ~~filings~~from ofits ~~periodic~~St. Petersburg, ~~reports~~Florida ~~and~~manufacturing, ~~the~~laboratory ~~steps the Company has taken~~ and ~~plans~~office tofacilities. ~~take~~The tocomplaint ~~become~~alleges ~~and remain~~ a ~~current~~claim ~~filer.~~for ~~Many~~more ofthan ~~these~~$1.7 ~~major~~million ~~difficulties~~in ~~have~~unpaid ~~been~~rent ~~described~~for in the ~~Form~~period ~~8-K~~of ~~filings LSI~~June 1, ~~has~~2004 ~~made~~through ~~since~~November ~~the beginning of 2004~~2008.

ItThe hearing is ~~unknown~~set ~~what~~to ~~course~~involve ofImlay’s ~~action the~~motion ~~Commission~~for ~~will~~default ~~take~~and orfinal ~~any~~judgment ~~related~~of ~~timing~~possession, and noLife ~~assurance~~Sciences’ ~~can~~motions beto ~~given~~determine ~~that~~rent, ~~the~~for stay ~~Commission~~and ~~will~~for ~~proceed in a manner other than as described in the April 7, 2005 letter~~mediation.

AsNew ~~indicated~~York inPremises ~~the~~Rent ~~Form~~Litigation ~~8-K filed on April 11, 2005, the Company anticipates the devotion of an additional portion of its limited resources to the satisfaction of filing obligations under the Securities Exchange Act.~~

2This action brought on August 12, 2008 in the U.S. District Court, Eastern District of New York, against Life Sciences for monetary damages exceeding $1,665,000 by Imlay, the same New York corporation controlled by Simon Srybnik and Louis D. Srybnik, awaits the Court’s ruling on Life Sciences’ motion filed on November 26, 2008 to vacate the clerk’s default entered against it, and the request of the same date for a pre-filing conference to discuss the filing of Life Sciences’ Rule 12(b) motions (motions to dismiss for insufficiency of process and for improper venue, and a motion to disqualify Imlay’s counsel).

SEC Filings

The ultimate objective(s) of Simon Srybnik and Louis D. Srybnik as the controlling shareholders of Life Sciences is unknown, as in apparent disregard of the requirements of Section 13(d) of the Securities Exchange Act of 1934 (15 USC §78m), and Regulation 13D (17 CFR 240.13d-1 et. seq.) and Schedule 13D (17 CFR 240.13d-101) as adopted thereunder by the Securities and Exchange Commission, they have never disclosed any such objectives in any apparently required filing of a Schedule 13D.

-2-

See also the Forms 8-K filed by Life Sciences with the SEC on November 10, 2008 (cover and signed date of September 16, 2008 and November 10, 2008, respectively), November 26, 2008 (cover and signed date of November 20, 2008 and November 26, 2008), and December 2, 2008 (cover and signed date of November 26, 2008 and December 2, 2008).

Conclusion

While Life Sciences believes it has various meritorious defenses to these legal actions brought against it by the entities controlled by Simon Srybnik and Louis D. Srybnik, the ultimate outcome of these matters is unknown but potentially devastating to the Company and its shareholders other than Simon Srybnik and Louis D. Srybnik and entities jointly owned and controlled by them.

-3-

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: ~~April 26~~January 9, ~~2005~~2009.

LIFE SCIENCES, INC. By: /s/ ~~Simon~~Alex ~~Srybnik~~A. ~~Simon~~Burns ~~Srybnik,~~Alex ~~Chairman~~A. Burns, ~~CEO~~Vice President and ~~President~~Secretary

3-4-

Filing Compare · LIFE SCIENCES INC